Research examines effects of embryonic exposure to environmental pollutants on risk of diabetes

A University of Massachusetts Amherst environmental health scientist has received a $2.44 million, five-year grant renewal from the National Institutes of Health (NIH) to continue her research into how embryonic exposure to certain common pollutants may put people at risk for diabetes and other metabolic health conditions later in life. A University of Massachusetts Amherst … Read more

COVID-19 patients more likely to develop cardiovascular diseases and diabetes soon after infection

Patients who contract COVID-19 face a higher risk of developing cardiovascular diseases and diabetes, particularly in the three months following infection, according to a new study by Emma Rezel-Potts, Martin Gulliford, and colleagues of King’s College London, United Kingdom, publishing July 19th in the open access journal PLOS Medicine. Credit: SHVETS production, Pexels (CC0, https://creativecommons.org/publicdomain/zero/1.0/) … Read more

Not enough men in their 40s are getting screened for diabetes: Study – BIOENGINEER.ORG

Not enough men in Alberta, Canada – especially those in their 40s – are getting tested for diabetes, putting them at risk for heart disease, cancer and other complications, according to new population health research published today in The Lancet Regional Health – Americas. Not enough men in Alberta, Canada – especially those in their … Read more

Diabetes patients on Medicare advantage plans more likely to have worse health, study finds – BIOENGINEER.ORG

PITTSBURGH, July 7, 2022 – While patients with diabetes on Medicare Advantage plans are more likely to receive preventive treatments, they were less likely to be prescribed newer, more expensive medications and were more likely to have higher blood pressure and worse blood glucose control than patients on Medicare Fee-For-Service plans, according to a new … Read more

A rhythmic small intestinal microbiome prevents obesity and type 2 diabetes – BIOENGINEER.ORG

An estimated 500 to 1,000 bacterial species reside in each person’s gut, perhaps numbering 100,000 trillion microorganisms. In a new paper, published July 5, 2022 in Cell Reportsresearchers at the University of California San Diego School of Medicine used mouse models to explore how diet and feeding patterns affect these intestinal microbes – and the … Read more

Western diets rich in fructose and fat cause diabetes via glycerate-mediated loss of pancreatic islet cells – BIOENGINEER.ORG

(LOS ANGELES) – June 9, 2022 – Those who are habitually inclined to consume burgers, fries and soda may think twice about their dietary choices following scientists’ latest findings about high-fat, high-fructose diets. (LOS ANGELES) – June 9, 2022 – Those who are habitually inclined to consume burgers, fries and soda may think twice about … Read more

Obesity can trigger type 1 diabetes, study finds

Credit: CC0 Public Domain. Scientists from Tel Aviv University found obesity also contributes to type 1 diabetes. They tested nearly 1.5 million Israeli teenagers and found that those who were obese were twice as likely to develop type 1 diabetes by young adulthood, versus those in the normal weight range. The research is published in … Read more

New study reveals the link between diabetes and high blood pressure

Credit: CC0 Public Domain. Scientists from the University of Bristol found why so many patients suffering from high blood pressure (known as hypertension) also have diabetes (high blood sugar). The key is a small protein cell glucagon-like peptide-1 (GLP-1) that couples the body’s control of blood sugar and blood pressure. The research is published in … Read more

Newly Approved Diabetes Drug Delivers Record-Breaking Weight Loss in Clinical Trial

A recently approved diabetes drug being clinically investigated for its effects on body weight in obese and overweight people has delivered “substantial and sustained reductions in body weight” in a phase 3 clinical trial, according to results now published in The New England Journal of Medicine. Tirzepatide, developed by American pharmaceutical company Eli Lilly and … Read more

Two common diabetes drugs could increase your heart attack risk

Credit: CC0 Public Domain In a recent study, researchers from Northwestern University found two drugs commonly prescribed to treat Type 2 diabetes carry a high risk of cardiovascular events, including heart attack, stroke, heart failure, or amputation. The two drugs — sulfonylureas and basal insulin — are commonly prescribed when metformin, a widely accepted initial … Read more